Prelude Therapeutics Inc — Investor Relations & Filings
Prelude Therapeutics is a clinical-stage precision oncology company focused on discovering and developing innovative medicines for cancer patients with high unmet needs. The company's pipeline features small molecule therapies and leverages expertise in targeted protein degradation. Key development programs include highly selective KAT6A degraders for solid tumors, such as ER+ breast cancer, and mutant-selective JAK2V617F JH2 inhibitors for myeloproliferative neoplasms. Prelude is also advancing next-generation degrader antibody conjugates (DACs) with novel payloads. The company's science-driven approach targets critical cancer cell pathways to create potentially transformative treatments.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K | 2023-02-14 | English | |
| Major Shareholding Notification 2023 | 2023-02-13 | English | |
| Major Shareholding Notification 2023 | 2023-02-10 | English | |
| SC 13G/A | 2023-02-10 | English | |
| PRIMARY DOCUMENT | 2023-02-09 | English | |
| PRIMARY DOCUMENT | 2023-02-09 | English |
Browse filings by year
11 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2023
12 filings
| |||||
| 12969599 | 8-K | 2023-02-14 | English | ||
| 12969600 | Major Shareholding Notification 2023 | 2023-02-13 | English | ||
| 12969601 | Major Shareholding Notification 2023 | 2023-02-10 | English | ||
| 12969602 | SC 13G/A | 2023-02-10 | English | ||
| 12969603 | PRIMARY DOCUMENT | 2023-02-09 | English | ||
| 12969604 | PRIMARY DOCUMENT | 2023-02-09 | English | ||
| 12969605 | PRIMARY DOCUMENT | 2023-02-09 | English | ||
| 12969606 | PRIMARY DOCUMENT | 2023-02-09 | English | ||
| 12969607 | PRIMARY DOCUMENT | 2023-02-09 | English | ||
| 12969608 | Major Shareholding Notification 2023 | 2023-02-09 | English | ||
| 12969609 | 8-K | 2023-01-23 | English | ||
| 12969610 | 8-K | 2023-01-09 | English | ||
|
2022
3 filings
| |||||
| 12969611 | PRIMARY DOCUMENT | 2022-12-22 | English | ||
| 12969612 | PRIMARY DOCUMENT | 2022-12-21 | English | ||
| 12969613 | PRIMARY DOCUMENT | 2022-12-12 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Prelude Therapeutics Inc via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34339/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34339 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34339 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34339 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34339}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Prelude Therapeutics Inc (id: 34339)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.